Gross Margin
30.66%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 22.11%.Updated Nov 22, 2026Profit Margin
9.37%vs Specialty Chemicals peers Updated Nov 22, 2026Operating Margin
10.85%vs Specialty Chemicals peers Updated Nov 22, 2026Return on Assets (TTM)
2.74%vs Specialty Chemicals peers Updated Nov 22, 2026Return on Equity (TTM)
4.25%vs Specialty Chemicals peers Updated Nov 22, 2026Revenue (TTM)
696.06MCNY88.10M · vs all stocks (USD) Updated Nov 22, 2026Revenue per Share (TTM)
1.24CNYUpdated Nov 22, 2026Quarterly Revenue Growth
101.90%vs Specialty Chemicals peers Updated Nov 22, 2026Gross Profit (TTM)
153.87MCNY13.60M · vs all stocks (USD) Updated Nov 22, 2026EBITDA (TTM)
41.54MCNY6.23M · vs all stocks (USD) Updated Nov 22, 2026Net Income (TTM)
65.24MCNY2.21M · vs all stocks (USD) Updated Nov 22, 2026Quarterly Earnings Growth (YoY)
8427.80%vs Specialty Chemicals peers Updated Nov 22, 2026Operating Cash Flow (TTM)
93.72MCNY7.64M · vs all stocks (USD) Updated Nov 22, 2026Levered Free Cash Flow (TTM)
-99.63MCNY-24.57M · vs all stocks (USD) Updated Nov 22, 20265-Year Average Dividend Yield
0.37%Updated Nov 22, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Nov 22, 2026Revenue
465.44MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
435.54MCNYFY2025 · Dec 31, 2025Gross Profit
29.90MCNYFY2025 · Dec 31, 2025Operating Income
-37.15MCNY-5.57M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-29.65MCNYFY2025 · Dec 31, 2025Income Tax Expense
-1.91MCNYFY2025 · Dec 31, 2025Net Income
-27.74MCNYFY2025 · Dec 31, 2025EBIT
-29.64MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
41.54MCNYFY2025 · Dec 31, 2025Research & Development
39.96MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
4.81MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.52MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
8.75MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
10.08KCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0493CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0493CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
562.72MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
562.72MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-27.74MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-15.91MCNYFY2025 · Dec 31, 2025Free Cash Flow
-183.67MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
138.23MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-27.74MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-3.26MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
14.14MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
949.57KCNYFY2025 · Dec 31, 2025Capital Expenditures
-167.75MCNYFY2025 · Dec 31, 2025Purchase of Investments
-164.82MCNYFY2025 · Dec 31, 2025Sale of Investments
200.52MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-132.05MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
10.78KCNYFY2025 · Dec 31, 2025Common Dividends Paid
-9.00MCNYFY2025 · Dec 31, 2025Other Financing Charges
-9.69MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-18.68MCNYFY2025 · Dec 31, 2025